← All trials

NCT05994001

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Aug 1, 2023
Primary completion
Aug 1, 2025
Completion date
Aug 1, 2026
First posted
Aug 16, 2023
Last posted
Aug 16, 2023
Enrollment
96
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.